Risk of bone overstimulation in long-term PTH(1-34) therapy for hypoparathyroidism. - Fischler R; Lecoq AL; Houillier P; Verdoux M; Vantyghem MC; Briot K; Besson FL; Pierquet-Ghazzar N; Beron A; Viengchareun S; Trabado S; Lecoeuvre A; et al. (European journal of endocrinology, 2026)